[{"address1": "9237 East Via de Ventura Boulevard", "address2": "Suite 105", "city": "Scottsdale", "state": "AZ", "zip": "85258", "country": "United States", "phone": "480 434 6670", "website": "https://journeymedicalcorp.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Claude  Maraoui", "age": 57, "title": "Founder, President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 975434, "exercisedValue": 0, "unexercisedValue": 4806250}, {"maxAge": 1, "name": "Mr. Joseph M. Benesch", "age": 57, "title": "CFO & Corporate Controller", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 434088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ramsey  Alloush", "age": 38, "title": "COO, General Counsel & Company Secretary", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Nevin", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jaclyn  Jaffe", "title": "Senior Director of Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Louis  Donati", "title": "Director of Market Access", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.07, "open": 8.09, "dayLow": 7.8272, "dayHigh": 8.135, "regularMarketPreviousClose": 8.07, "regularMarketOpen": 8.09, "regularMarketDayLow": 7.8272, "regularMarketDayHigh": 8.135, "payoutRatio": 0.0, "forwardPE": -134.33334, "volume": 57061, "regularMarketVolume": 57061, "averageVolume": 90919, "averageVolume10days": 98250, "averageDailyVolume10Day": 98250, "bid": 7.91, "ask": 8.1, "bidSize": 1, "askSize": 1, "marketCap": 187764160, "fiftyTwoWeekLow": 3.535, "fiftyTwoWeekHigh": 8.24, "priceToSalesTrailing12Months": 3.338445, "fiftyDayAverage": 6.7369, "twoHundredDayAverage": 5.508975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 191860896, "profitMargins": -0.14762999, "floatShares": 10928278, "sharesOutstanding": 17295800, "sharesShort": 315981, "sharesShortPriorMonth": 252109, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.0136, "heldPercentInsiders": 0.67541003, "heldPercentInstitutions": 0.29053, "shortRatio": 3.33, "shortPercentOfFloat": 0.026600001, "impliedSharesOutstanding": 23295800, "bookValue": 0.932, "priceToBook": 8.648069, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -8303000, "trailingEps": -0.37, "forwardEps": -0.06, "enterpriseToRevenue": 3.411, "enterpriseToEbitda": -59.29, "52WeekChange": 1.009975, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 8.06, "targetHighPrice": 11.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.75, "targetMedianPrice": 9.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 21070000, "totalCashPerShare": 0.904, "ebitda": -3236000, "totalDebt": 25167000, "quickRatio": 0.972, "currentRatio": 1.342, "totalRevenue": 56243000, "debtToEquity": 116.833, "revenuePerShare": 2.66, "returnOnAssets": -0.057010002, "returnOnEquity": -0.48144, "grossProfits": 36576000, "freeCashflow": -18661250, "operatingCashflow": -6940000, "revenueGrowth": 0.008, "grossMargins": 0.65032, "ebitdaMargins": -0.057540003, "operatingMargins": -0.25299, "financialCurrency": "USD", "symbol": "DERM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestamp": 1747252800, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755028800, "earningsCallTimestampStart": 1747254600, "earningsCallTimestampEnd": 1747254600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.37, "epsForward": -0.06, "fiftyDayAverageChange": 1.3231006, "fiftyDayAverageChangePercent": 0.19639605, "twoHundredDayAverageChange": 2.5510254, "twoHundredDayAverageChangePercent": 0.46306714, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-12", "cryptoTradeable": false, "postMarketChangePercent": 0.0, "postMarketPrice": 8.06, "postMarketChange": 0.0, "regularMarketChange": -0.00999928, "regularMarketDayRange": "7.8272 - 8.135", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 90919, "fiftyTwoWeekLowChange": 4.5250006, "fiftyTwoWeekLowChangePercent": 1.2800567, "fiftyTwoWeekRange": "3.535 - 8.24", "fiftyTwoWeekHighChange": -0.17999935, "fiftyTwoWeekHighChangePercent": -0.021844583, "fiftyTwoWeekChangePercent": 100.9975, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636727400000, "shortName": "Journey Medical Corporation", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1748635443, "regularMarketTime": 1748635202, "exchange": "NCM", "messageBoardId": "finmb_280596341", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.123907, "regularMarketPrice": 8.06, "longName": "Journey Medical Corporation", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]